-
1
-
-
20444460289
-
MicroRNA expression profiles classify human cancers
-
DOI 10.1038/nature03702
-
J. Lu, G. Getz, E.A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B.L. Ebert, R.H. Mak, and A.A. Ferrando MicroRNA expression profiles classify human cancers Nature 435 2005 834 838 (Pubitemid 40839735)
-
(2005)
Nature
, vol.435
, Issue.7043
, pp. 834-838
-
-
Lu, J.1
Getz, G.2
Miska, E.A.3
Alvarez-Saavedra, E.4
Lamb, J.5
Peck, D.6
Sweet-Cordero, A.7
Ebert, B.L.8
Mak, R.H.9
Ferrando, A.A.10
Downing, J.R.11
Jacks, T.12
Horvitz, H.R.13
Golub, T.R.14
-
2
-
-
72049115805
-
MicroRNA 125a and its regulation of the p53 tumor suppressor gene
-
Y. Zhang, J.S. Gao, X. Tang, L.D. Tucker, P. Quesenberry, I. Rigoutsos, and B. Ramratnam MicroRNA 125a and its regulation of the p53 tumor suppressor gene FEBS Lett. 583 2009 3725 3730
-
(2009)
FEBS Lett.
, vol.583
, pp. 3725-3730
-
-
Zhang, Y.1
Gao, J.S.2
Tang, X.3
Tucker, L.D.4
Quesenberry, P.5
Rigoutsos, I.6
Ramratnam, B.7
-
3
-
-
20044395613
-
RAS is regulated by the let-7 microRNA family
-
DOI 10.1016/j.cell.2005.01.014
-
S.M. Johnson, H. Grosshans, J. Shingara, M. Byrom, R. Jarvis, A. Cheng, E. Labourier, K.L. Reinert, D. Brown, and F.J. Slack RAS is regulated by the let-7 microRNA family Cell 120 2005 635 647 (Pubitemid 40343076)
-
(2005)
Cell
, vol.120
, Issue.5
, pp. 635-647
-
-
Johnson, S.M.1
Grosshans, H.2
Shingara, J.3
Byrom, M.4
Jarvis, R.5
Cheng, A.6
Labourier, E.7
Reinert, K.L.8
Brown, D.9
Slack, F.J.10
-
4
-
-
64349101658
-
MicroRNA-125b is a novel negative regulator of p53
-
M.T. Le, C. Teh, N. Shyh-Chang, H. Xie, B. Zhou, V. Korzh, H.F. Lodish, and B. Lim MicroRNA-125b is a novel negative regulator of p53 Genes Dev. 23 2009 862 876
-
(2009)
Genes Dev.
, vol.23
, pp. 862-876
-
-
Le, M.T.1
Teh, C.2
Shyh-Chang, N.3
Xie, H.4
Zhou, B.5
Korzh, V.6
Lodish, H.F.7
Lim, B.8
-
5
-
-
65549098881
-
Decreased expression of microRNA-143 and -145 in human gastric cancers
-
T. Takagi, A. Iio, Y. Nakagawa, T. Naoe, N. Tanigawa, and Y. Akao Decreased expression of microRNA-143 and -145 in human gastric cancers Oncology 77 2009 12 21
-
(2009)
Oncology
, vol.77
, pp. 12-21
-
-
Takagi, T.1
Iio, A.2
Nakagawa, Y.3
Naoe, T.4
Tanigawa, N.5
Akao, Y.6
-
6
-
-
33846887975
-
MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers
-
Y. Akao, Y. Nakagawa, and T. Naoe MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers Oncol. Rep. 16 2006 845 850
-
(2006)
Oncol. Rep.
, vol.16
, pp. 845-850
-
-
Akao, Y.1
Nakagawa, Y.2
Naoe, T.3
-
7
-
-
33748587841
-
A Pattern-Based Method for the Identification of MicroRNA Binding Sites and Their Corresponding Heteroduplexes
-
DOI 10.1016/j.cell.2006.07.031, PII S0092867406010993
-
K.C. Miranda, T. Huynh, Y. Tay, Y.S. Ang, W.L. Tam, A.M. Thomson, B. Lim, and I. Rigoutsos A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes Cell 126 2006 1203 1217 (Pubitemid 44380294)
-
(2006)
Cell
, vol.126
, Issue.6
, pp. 1203-1217
-
-
Miranda, K.C.1
Huynh, T.2
Tay, Y.3
Ang, Y.-S.4
Tam, W.-L.5
Thomson, A.M.6
Lim, B.7
Rigoutsos, I.8
-
8
-
-
62249137047
-
Role of miR-143 targeting KRAS in colorectal tumorigenesis
-
X. Chen, X. Guo, H. Zhang, Y. Xiang, J. Chen, Y. Yin, X. Cai, K. Wang, G. Wang, and Y. Ba Role of miR-143 targeting KRAS in colorectal tumorigenesis Oncogene 28 2009 1385 1392
-
(2009)
Oncogene
, vol.28
, pp. 1385-1392
-
-
Chen, X.1
Guo, X.2
Zhang, H.3
Xiang, Y.4
Chen, J.5
Yin, Y.6
Cai, X.7
Wang, K.8
Wang, G.9
Ba, Y.10
-
9
-
-
33645294070
-
Oncomirs - MicroRNAs with a role in cancer
-
A. Esquela-Kerscher, and F.J. Slack Oncomirs - microRNAs with a role in cancer Nat. Rev. Cancer 6 2006 259 269
-
(2006)
Nat. Rev. Cancer
, vol.6
, pp. 259-269
-
-
Esquela-Kerscher, A.1
Slack, F.J.2
-
10
-
-
0142120587
-
Reduced Accumulation of Specific MicroRNAs in Colorectal Neoplasia
-
M.Z. Michael, S.M. O'Connor, N.G. van Holst Pellekaan, G.P. Young, and R.J. James Reduced accumulation of specific microRNAs in colorectal neoplasia Mol. Cancer Res. 1 2003 882 891 (Pubitemid 37288707)
-
(2003)
Molecular Cancer Research
, vol.1
, Issue.12
, pp. 882-891
-
-
Michael, M.Z.1
O'Connor, S.M.2
Van Holst Pellekaan, N.G.3
Young, G.P.4
James, R.J.5
-
11
-
-
33747334621
-
Extensive post-transcriptional regulation of microRNAs and its implications for cancer
-
J.M. Thomson, M. Newman, J.S. Parker, E.M. Morin-Kensicki, T. Wright, and S.M. Hammond Extensive post-transcriptional regulation of microRNAs and its implications for cancer Genes Dev. 20 2006 2202 2207
-
(2006)
Genes Dev.
, vol.20
, pp. 2202-2207
-
-
Thomson, J.M.1
Newman, M.2
Parker, J.S.3
Morin-Kensicki, E.M.4
Wright, T.5
Hammond, S.M.6
-
13
-
-
34250677675
-
The oncogene and developmental regulator EVI1: Expression, biochemical properties, and biological functions
-
DOI 10.1016/j.gene.2007.04.012, PII S0378111907001849
-
R. Wieser The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions Gene 396 2007 346 357 (Pubitemid 46935408)
-
(2007)
Gene
, vol.396
, Issue.2
, pp. 346-357
-
-
Wieser, R.1
-
14
-
-
0031173051
-
The EviI proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development
-
DOI 10.1016/S0925-4773(97)00057-9, PII S0925477397000579
-
P.R. Hoyt, C. Bartholomew, A.J. Davis, K. Yutzey, L.W. Gamer, S.S. Potter, J.N. Ihle, and M.L. Mucenski The Evi1 proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development Mech. Dev. 65 1997 55 70 (Pubitemid 27314591)
-
(1997)
Mechanisms of Development
, vol.65
, Issue.1-2
, pp. 55-70
-
-
Hoyt, P.R.1
Bartholomew, C.2
Davis, A.J.3
Yutzey, K.4
Gamer, L.W.5
Potter, S.S.6
Ihle, J.N.7
Mucenski, M.L.8
-
15
-
-
0036736530
-
The human promyelocytic leukemia zinc finger gene is regulated by the Evi-1 oncoprotein and a novel guanine-rich site binding protein
-
S. Takahashi, and J.D. Licht The human promyelocytic leukemia zinc finger gene is regulated by the Evi-1 oncoprotein and a novel guanine-rich site binding protein Leukemia 16 2002 1755 1762
-
(2002)
Leukemia
, vol.16
, pp. 1755-1762
-
-
Takahashi, S.1
Licht, J.D.2
-
16
-
-
34548746977
-
MicroRNA signatures in human ovarian cancer
-
DOI 10.1158/0008-5472.CAN-07-1936
-
M.V. Iorio, R. Visone, G. Di Leva, V. Donati, F. Petrocca, P. Casalini, C. Taccioli, S. Volinia, C.G. Liu, and H. Alder MicroRNA signatures in human ovarian cancer Cancer Res. 67 2007 8699 8707 (Pubitemid 47437445)
-
(2007)
Cancer Research
, vol.67
, Issue.18
, pp. 8699-8707
-
-
Iorio, M.V.1
Visone, R.2
Di Leva, G.3
Donati, V.4
Petrocca, F.5
Casalini, P.6
Taccioli, C.7
Volinia, S.8
Liu, C.-G.9
Alder, H.10
Calin, G.A.11
Menard, S.12
Croce, C.M.13
-
17
-
-
34248219165
-
Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer
-
DOI 10.1158/0008-5472.CAN-06-2366
-
M. Nanjundan, Y. Nakayama, K.W. Cheng, J. Lahad, J. Liu, K. Lu, W.L. Kuo, K. Smith-McCune, D. Fishman, and J.W. Gray Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer Cancer Res. 67 2007 3074 3084 (Pubitemid 46724844)
-
(2007)
Cancer Research
, vol.67
, Issue.7
, pp. 3074-3084
-
-
Nanjundan, M.1
Nakayama, Y.2
Kwai, W.C.3
Lahad, J.4
Liu, J.5
Lu, K.6
Kuo, W.-L.7
Smith-McCune, K.8
Fishman, D.9
Gray, J.W.10
Mills, G.B.11
-
18
-
-
37049019490
-
MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy
-
DOI 10.1158/0008-5472.CAN-07-2858
-
J.B. Weidhaas, I. Babar, S.M. Nallur, P. Trang, S. Roush, M. Boehm, E. Gillespie, and F.J. Slack MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy Cancer Res. 67 2007 11111 11116 (Pubitemid 350248533)
-
(2007)
Cancer Research
, vol.67
, Issue.23
, pp. 11111-11116
-
-
Weidhaas, J.B.1
Babar, I.2
Nallur, S.M.3
Trang, P.4
Roush, S.5
Boehm, M.6
Gillespie, E.7
Slack, F.J.8
-
19
-
-
33745180526
-
Evi1 is a survival factor which conveys resistance to both TGFβ- and taxol-mediated cell death via PI3K/AKT
-
DOI 10.1038/sj.onc.1209403, PII 1209403
-
Y. Liu, L. Chen, T.C. Ko, A.P. Fields, and E.A. Thompson Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K/AKT Oncogene 25 2006 3565 3575 (Pubitemid 43901678)
-
(2006)
Oncogene
, vol.25
, Issue.25
, pp. 3565-3575
-
-
Liu, Y.1
Chen, L.2
Ko, T.C.3
Fields, A.P.4
Thompson, E.A.5
-
20
-
-
77953087435
-
Methylation and silencing of miRNA-124 by EVI1 and self-renewal exhaustion of hematopoietic stem cells in murine myelodysplastic syndrome
-
J. Dickstein, V. Senyuk, K. Premanand, L. Laricchia-Robbio, P. Xu, F. Cattaneo, R. Fazzina, and G. Nucifora Methylation and silencing of miRNA-124 by EVI1 and self-renewal exhaustion of hematopoietic stem cells in murine myelodysplastic syndrome Proc. Natl. Acad. Sci. USA 107 2010 9783 9788
-
(2010)
Proc. Natl. Acad. Sci. USA
, vol.107
, pp. 9783-9788
-
-
Dickstein, J.1
Senyuk, V.2
Premanand, K.3
Laricchia-Robbio, L.4
Xu, P.5
Cattaneo, F.6
Fazzina, R.7
Nucifora, G.8
|